2000, Pages 165–184
Chapter 8 – Optimizing the Reaction by Minimizing Impurities
- Process Solutions L.L.C., Nicasio, California
The goals of process optimization change with the successful development of a project from early process research through scale-up into dedicated manufacturing. This general order of optimization may differ according to the nature of the process being considered; for instance, a process generating an inordinate amount of waste may be optimized to decrease waste before scaling up to the pilot plant. The initial goal of all process research and development is to maximize the amount of product generated under the reaction conditions. This is done by driving the reaction to completion, that is, by consuming any starting material that is charged in limiting amounts and by generating product with a minimal amount of by-products. Once the in-process yield has been optimized, the maximum yield of isolated product is expected. Rapid optimization is possible by judiciously changing solvents, reagents, catalysts, and ligands; investigations in this area allow the chemist considerable room for creativity and simplifying a process. Such changes may generate different impurities in the isolated intermediates, and it may be necessary to examine the tolerance of subsequent processes for the new impurities.
-
Chapter 8 – Optimizing the Reaction by Minimizing Impurities
-
Neal G. Anderson, PhD
For the past 17 years Neal has consulted to the pharmaceutical and fine chemical industries on chemical process research and development. He has presented short courses internationally on process R&D for “small molecules” to over 1400 participants from more than 160 companies. Keys to efficient scale-up are anticipating and then avoiding diffiulcties. Prior to consulting he worked at Bristol-Myers Squibb for 17 years. During that time, he had extensive hands-on experience with chemical process R&D in the lab, pilot plant, and manufacturing sites, including 12 manufacturing start-ups and process development for four major drugs. He is the author of Practical Process Research & Development(Academic Press; 2nd edition 2012).
Education & Training
- 1977-1979, post-doctoral studies, McNeil Laboratories
- 1977, Ph.D., Medicinal Chemistry, University of Michigan
- 1972, B.Sc., Honors Biology, University of Illinois
I consult to the pharmaceutical and fine chemical industries on developing and trouble-shooting processes to efficiently prepare drug substances and intermediates on large scale. Anticipating and avoiding problems are key for effective and efficient scale-up. For 17 years I have been consulting and presenting short courses internationally on process chemistry R & D for “small molecules” (over 1400 participants from more than 160 companies). Prior to consulting I worked at Bristol-Myers Squibb for 17 years. During that time I had extensive hands-on experience with chemical process development in the lab, pilot plant, and manufacturing sites, including 12 manufacturing start-ups and process development for four major drugs and many new drug candidates. I wrote Practical Process Research & Development (Academic Press, 2000; 2nd edition 2012).
Practical Process Research & Development describes the development of chemical processes for the pharmaceutical and fine chemicals industries. It provides a comprehensive, step-by-step approach to process R & D, and it is designed for those who want insights into generating rugged, practical, cost-effective processes. Guidelines for industrial process R & D are rarely taught in academia, although this book has been used as a textbook. It is primarily used by those in industry.
The second edition updates the first edition and includes topics not covered in the first edition, such as genotoxins, biocatalysis, green solvents, predicting effective solvent combinations, and process validation. Almost 85% of the references cited were published after the first edition was published, and virtually all examples in the Figures are new. Trevor Laird kindly wrote a forward for this edition.
The second edition has been translated into Japanese and graced with a handsome cover. Noriaki Murase was the translation supervisor, and the translators were Shohei Imachi, Koreaki Imura, Dai Tatsuta, Taro Tsukude, Toyoharu Numata, Yujiro Furuya, Akira Manaka, and Noriaki Murase. Sayaka Nukatsuka was the editor. I am very grateful to these people for their hard work to translate my book.
I am grateful to Barry Sharpless and Jerry Moniot for writing forwards to the first edition I am also grateful to the following people for their translations of the first edition of my book. Noriaki Murase, Yoshinori Murata, Toyoharu Numata, Mio Sakai, and Tatsuo Ueki translated Practical Process Research & Development into Japanese. Kwang-Hyun Ahn, Yeung-Ho Park, and Sung-Kwan Hwang translated Practical Process Research & Development into Korean. Zhinong Gao and Wenhao Hu translated Practical Process Research & Development into Chinese.
- Evaluate the existing synthesis and identify steps, or sequences in the route that may pose a problem for large scale synthesis
- Propose alternatives to any problematic steps or sequences and then implement these alternatives bases upon laboratory experimentation using Ph.D. level chemists with process research expertise
- Ensure the synthesis is suitable for the immediate needs of the project, which maybe for only a few kilograms of API
- Ensure the synthesis is suitable for long term, large scale manufacturing
- Optimize reagent charges, operating temperatures, concentrations, work-up conditions and volumes, and solvent use in general
- Identify which steps can be combined to result in a “through process” and implement the through process
- Optimize purification schemes by identifying key crystalline intermediates and remove chromatographies from the synthesis
- Optimize recrystallization parameters to ensure consistently high purity with similar impurity profiles from batch to batch, with low mother liquor losses
- Institute appropriate analytical controls for in-process assays, end of reaction specifications, and acceptable intermediate or API purity
- The process research team works closely with the analytical team to integrate the chemistry and analytical controls into the process at an early stage of the development cycle. The process research is then documented into a JACS style development report that outlines the chemistry and synthetic approaches that were tried as part of the synthetic development effort. This development report also includes a detailed experimental with supporting analytical data for the successful chemistry that results from our effort.The experimental that is part of these development reports is much more detailed than any journal publication. When coupled with our analytical and cGMP capabilities, the process research we provide is an essential groundwork for any compound that is just advancing from nomination at the discovery phase into clinical trial development. The process we develop provides the foundation of the ultimate manufacturing process, and should not need any changes (at a later date), to the synthetic strategy or bond forming steps used to prepare the API.
Filed under: PROCESS, Promising clips Tagged: Minimizing Impurities, Optimizing the Reaction